Elena
Vuelta Ramos
Instituto de Investigación Biomédica de Salamanca
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Biomédica de Salamanca (7)
2023
-
A Potential Effect of Circadian Rhythm in the Delivery/Therapeutic Performance of Paclitaxel–Dendrimer Nanosystems
Journal of Functional Biomaterials, Vol. 14, Núm. 7
2022
-
CRISPR/Cas9‐Directed Gene Trap Constitutes a Selection System for Corrected BCR/ABL Leukemic Cells in CML
International Journal of Molecular Sciences, Vol. 23, Núm. 12
2021
-
CRISPR-Cas9 Technology as a Tool to Target Gene Drivers in Cancer: Proof of Concept and New Opportunities to Treat Chronic Myeloid Leukemia
CRISPR Journal, Vol. 4, Núm. 4, pp. 519-535
-
Future approaches for treating chronic myeloid leukemia: Crispr therapy
Biology, Vol. 10, Núm. 2, pp. 1-16
-
Stroma-Mediated Resistance to S63845 and Venetoclax through MCL-1 and BCL-2 Expression Changes Induced by miR-193b-3p and miR-21-5p Dysregulation in Multiple Myeloma
Cells, Vol. 10, Núm. 3
2020
-
Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology
Molecular Biology Reports, Vol. 47, Núm. 2, pp. 1381-1391
2019
-
Splice donor site sgRNAs enhance CRISPR/ Cas9-mediated knockout efficiency
PLoS ONE, Vol. 14, Núm. 5